Bio Rad Laboratories Inc (NYSE:BIO)
| 353.27 Delayed Data As of Sep 22 |  -4.03 / -1.13%Today’s Change | 344.63 Today|||52-Week Range 509.62 | -15.99% Year-to-Date |
Latest BIO News | Press Releases
| New Strong Sell Stocks for September 19th Sep 19 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 357.30 |
| Today’s open | 354.28 |
| Day’s range | 352.14 - 358.20 |
| Volume | 104,276 |
| Average volume (3 months) | 205,202 |
| Market cap | $8.5B |
Data as of 4:00pm ET, 09/22/2023
Growth & Valuation
| Earnings growth (last year) | -185.57% |
| Earnings growth (this year) | -5.40% |
| Earnings growth (next 5 years) | +6.00% |
| Revenue growth (last year) | -4.12% |
| P/E ratio | NM |
| Price/Sales | 4.47 |
| Price/Book | 1.09 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| QGENQiagen NV | -0.19 | -0.48% |
| BRKRBruker Corp | +0.01 | +0.02% |
| RVTYRevvity Inc | +1.01 | +0.93% |
| ---- |
Data as of 3:59pm ET, 09/22/2023
Financials
| Next reporting date | October 26, 2023 |
| EPS forecast (this quarter) | $3.30 |
| Annual revenue (last year) | $2.8B |
| Annual profit (last year) | -$3.6B |
| Net profit margin | -129.45% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Hercules, California |
Forecasts
